Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77551-77600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05669872
Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer
NANot yet recruiting
334 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05803343
Evaluating Additive Effects of Including Canines in Regulating Together
PHASE2Recruiting
240 participants
Started: Feb 28, 2023 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT06826820
Fertility: Infection and Inflammation
N/ARecruiting
800 participants
Started: Feb 28, 2023 · Completed: Dec 20, 2032
1 condition1 sponsor1 location
NCT05721573
A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis
PHASE2/PHASE3Active, not recruiting
231 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors45 locations
NCT05744479
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
PHASE4Recruiting
100 participants
Started: Feb 28, 2023 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05691114
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease
PHASE1Recruiting
18 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05750576
Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
NANot yet recruiting
270 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor0 locations
NCT06699017
Effect of Continuous Anterior Chest Compression on Ventilation/Perfusion Ratio and Hemodynamics
NARecruiting
20 participants
Started: Feb 28, 2023 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05774938
QoL After Complex Endovascular Aortic Repair
N/ARecruiting
90 participants
Started: Feb 28, 2023 · Completed: Jan 31, 2030
3 conditions1 sponsor1 location
NCT06597838
Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
N/ARecruiting
161,876 participants
Started: Feb 28, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05715931
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
PHASE2Recruiting
30 participants
Started: Feb 28, 2023 · Completed: Mar 1, 2028
3 conditions1 sponsor8 locations
NCT06344962
Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection
NARecruiting
40 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05712707
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2025
2 conditions6 sponsors4 locations
NCT05658523
COVID-19 Booster Study in Healthy Adults in Australia
PHASE3Active, not recruiting
497 participants
Started: Feb 28, 2023 · Completed: Oct 31, 2024
1 condition3 sponsors1 location
NCT06051136
Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer
NAActive, not recruiting
40 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05516628
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
PHASE2Recruiting
30 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2027
1 condition14 sponsors6 locations
NCT05445648
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
PHASE2Not yet recruiting
65 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05709626
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
PHASE4Recruiting
2,258 participants
Started: Feb 28, 2023 · Completed: Jan 4, 2028
1 condition2 sponsors1 location
NCT05641493
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation
PHASE1/PHASE2Recruiting
49 participants
Started: Feb 28, 2023 · Completed: Feb 27, 2026
1 condition1 sponsor1 location
NCT05566223
CISH Inactivated TILs in the Treatment of NSCLC
PHASE1/PHASE2Not yet recruiting
70 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2027
6 conditions1 sponsor2 locations
NCT05765929
Use of Weightbearing Radiographs to Determine Treatment of bi- and Trimalleolar Ankle Fractures
NARecruiting
29 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05712473
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
N/ANot yet recruiting
500 participants
Started: Feb 28, 2023 · Completed: Jun 30, 2029
1 condition2 sponsors0 locations
NCT05664139
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
PHASE2Not yet recruiting
30 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors0 locations
NCT05704218
Hypersensitivity Pneumonitis of Domestic Origin
NANot yet recruiting
500 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2026
3 conditions1 sponsor0 locations
NCT05760391
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
NARecruiting
100 participants
Started: Feb 28, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06430125
Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus
PHASE3Recruiting
46 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT04761146
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
NARecruiting
10 participants
Started: Feb 28, 2023 · Completed: Jan 1, 2026
3 conditions2 sponsors1 location
NCT05798117
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
PHASE1/PHASE2Active, not recruiting
21 participants
Started: Feb 28, 2023 · Completed: Sep 9, 2026
2 conditions1 sponsor12 locations
NCT05738707
Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
N/ANot yet recruiting
100 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor0 locations
NCT05434273
Effects of Integrated Cardiovascular Health Education Program on Older Adults at Risk of ASCVD
NANot yet recruiting
190 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT05650710
Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation
NARecruiting
50 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05715398
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer
PHASE1/PHASE2Not yet recruiting
90 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05443594
A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation
NAActive, not recruiting
669 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor44 locations
NCT04900792
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PHASE1Active, not recruiting
17 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05745454
A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors
NANot yet recruiting
12 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05698992
Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer
N/ARecruiting
100 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT05666713
NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial
NAActive, not recruiting
139 participants
Started: Feb 27, 2023 · Completed: May 14, 2025
2 conditions1 sponsor10 locations
NCT05734729
Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes
NARecruiting
120 participants
Started: Feb 27, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05626426
Electrical Stimulation for the Treatment of Optic Neuropathies
NARecruiting
40 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05819229
Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection
N/ARecruiting
125 participants
Started: Feb 27, 2023 · Completed: May 1, 2025
1 condition2 sponsors4 locations
NCT05847855
Multi-dimensional Fragmentomic Assay for Early Detection of Pancreatic Neuroendocrine Tumors
N/ARecruiting
440 participants
Started: Feb 27, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06092437
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
NARecruiting
466 participants
Started: Feb 27, 2023 · Completed: Aug 27, 2026
1 condition1 sponsor2 locations
NCT06073535
The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction
NAActive, not recruiting
40 participants
Started: Feb 27, 2023 · Completed: Dec 29, 2023
2 conditions1 sponsor1 location
NCT05752318
Analysis of the Persistence, Reservoir and HIV Latency
N/ANot yet recruiting
500 participants
Started: Feb 27, 2023 · Completed: Feb 25, 2027
2 conditions1 sponsor0 locations
NCT05666960
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
PHASE1Recruiting
36 participants
Started: Feb 27, 2023 · Completed: Oct 31, 2025
4 conditions3 sponsors3 locations
NCT06534944
NAD Supplementation and Vascular Health in PAD
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Feb 27, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05355363
Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay
NARecruiting
730 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05226663
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer
PHASE2Recruiting
36 participants
Started: Feb 27, 2023 · Completed: Aug 20, 2026
1 condition3 sponsors3 locations
NCT05605379
CML Pediatric ITK Response According to Molecular Identification at Diagnosis
N/ARecruiting
88 participants
Started: Feb 27, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06346119
Evaluation of the Impact of Touch Relaxation in Sedated Intubated Patients Hospitalized in Intensive Care at Niort Hospital
NARecruiting
72 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location